296 related articles for article (PubMed ID: 30466014)
1. Self-assessment of negative symptoms - Critical appraisal of the motivation and pleasure - Self-report's (MAP-SR) validity and reliability.
Richter J; Hesse K; Eberle MC; Eckstein KN; Zimmermann L; Schreiber L; Burmeister CP; Wildgruber D; Klingberg S
Compr Psychiatry; 2019 Jan; 88():22-28. PubMed ID: 30466014
[TBL] [Abstract][Full Text] [Related]
2. Validation and extension of the Motivation and Pleasure Scale-Self Report (MAP-SR) across the schizophrenia spectrum in the Chinese context.
Wang LL; Ma EPY; Lui SSY; Cheung EFC; Cheng KS; Chan RCK
Asian J Psychiatr; 2020 Mar; 49():101971. PubMed ID: 32065963
[TBL] [Abstract][Full Text] [Related]
3. Evidence for two distinct domains of negative symptoms: Confirming the factorial structure of the CAINS.
Richter J; Hesse K; Schreiber L; Burmeister CP; Eberle MC; Eckstein KN; Zimmermann L; Wildgruber D; Klingberg S
Psychiatry Res; 2019 Jan; 271():693-701. PubMed ID: 30791343
[TBL] [Abstract][Full Text] [Related]
4. The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms.
Llerena K; Park SG; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
Compr Psychiatry; 2013 Jul; 54(5):568-74. PubMed ID: 23351831
[TBL] [Abstract][Full Text] [Related]
5. Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia.
Engel M; Lincoln TM
Compr Psychiatry; 2016 Feb; 65():110-5. PubMed ID: 26773998
[TBL] [Abstract][Full Text] [Related]
6. The Swedish version of the Motivation and Pleasure Scale self-report (MAP-SR): psychometric properties in patients with schizophrenia or depression.
Cernvall M; Bengtsson J; Bodén R
Nord J Psychiatry; 2024 May; 78(4):339-346. PubMed ID: 38436927
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.
Kring AM; Gur RE; Blanchard JJ; Horan WP; Reise SP
Am J Psychiatry; 2013 Feb; 170(2):165-72. PubMed ID: 23377637
[TBL] [Abstract][Full Text] [Related]
8. Concordance of self- and observer-rated motivation and pleasure in patients with negative symptoms and healthy controls.
Engel M; Lincoln TM
Psychiatry Res; 2017 Jan; 247():1-5. PubMed ID: 27863311
[TBL] [Abstract][Full Text] [Related]
9. Measurement of negative and depressive symptoms: Discriminatory relevance of affect and expression.
Richter J; Hölz L; Hesse K; Wildgruber D; Klingberg S
Eur Psychiatry; 2019 Jan; 55():23-28. PubMed ID: 30384108
[TBL] [Abstract][Full Text] [Related]
10. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.
Blanchard JJ; Bradshaw KR; Garcia CP; Nasrallah HA; Harvey PD; Casey D; Csoboth CT; Hudson JI; Julian L; Lentz E; Nuechterlein KH; Perkins DO; Skale TG; Snowden LR; Tandon R; Tek C; Velligan D; Vinogradov S; O'Gorman C
Schizophr Res; 2017 Jul; 185():137-143. PubMed ID: 28087270
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
[TBL] [Abstract][Full Text] [Related]
12. Spanish Validation of the MAP-SR: Two Heads Better Than One for the Assessment of Negative Symptoms of Schizophrenia.
García-Portilla MP; García-Álvarez L; de la Fuente-Tomás L; Dal Santo F; Velasco A; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Bobes-Bascarán MT; Sáiz PA; Bobes J
Psicothema; 2021 Aug; 33(3):473-480. PubMed ID: 34297678
[TBL] [Abstract][Full Text] [Related]
13. Cross Cultural Validation and Extension of the Clinical Assessment Interview for Negative Symptoms (CAINS) in the Chinese Context: Evidence from a Spectrum Perspective.
Xie DJ; Shi HS; Lui SSY; Shi C; Li Y; Ho KKY; Hung KSY; Li WX; Yi ZH; Cheung EFC; Kring AM; Chan RCK
Schizophr Bull; 2018 Oct; 44(suppl_2):S547-S555. PubMed ID: 29471331
[TBL] [Abstract][Full Text] [Related]
14. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
[TBL] [Abstract][Full Text] [Related]
15. Investigating consummatory and anticipatory pleasure across motivation deficits in schizophrenia and healthy controls.
Da Silva S; Saperia S; Siddiqui I; Fervaha G; Agid O; Daskalakis ZJ; Ravindran A; Voineskos AN; Zakzanis KK; Remington G; Foussias G
Psychiatry Res; 2017 Aug; 254():112-117. PubMed ID: 28460280
[TBL] [Abstract][Full Text] [Related]
16. The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.
Bischof M; Obermann C; Hartmann MN; Hager OM; Kirschner M; Kluge A; Strauss GP; Kaiser S
BMC Psychiatry; 2016 Nov; 16(1):415. PubMed ID: 27876020
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of anhedonia with the Snaith-Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder.
Nakonezny PA; Morris DW; Greer TL; Byerly MJ; Carmody TJ; Grannemann BD; Bernstein IH; Trivedi MH
J Psychiatr Res; 2015 Jun; 65():124-30. PubMed ID: 25864641
[TBL] [Abstract][Full Text] [Related]
18. Psychometric evaluation of the Temporal Experience of Pleasure Scale (TEPS) in a German sample.
Simon JJ; Zimmermann J; Cordeiro SA; Marée I; Gard DE; Friederich HC; Weisbrod M; Kaiser S
Psychiatry Res; 2018 Feb; 260():138-143. PubMed ID: 29195165
[TBL] [Abstract][Full Text] [Related]
19. Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).
Engel M; Fritzsche A; Lincoln TM
Psychiatry Res; 2014 Dec; 220(1-2):659-63. PubMed ID: 25138895
[TBL] [Abstract][Full Text] [Related]
20. The Latent Structure of Negative Symptoms in Schizophrenia.
Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
